Skip to main content
Log in

Patient Preferences for an Oral Anticoagulant after Major Orthopedic Surgery

Results of a German Survey

  • Original Research Article
  • Published:
The Patient: Patient-Centered Outcomes Research Aims and scope Submit manuscript

Abstract

Background: Since 2008, the availability of the oral direct thrombin inhibitor dabigatran etexilate provides a further therapeutic alternative to injectable low-molecular-weight heparin (LMWH) for thromboprophylaxis following hip or knee replacement surgery. The intention of this study is to analyze patient preferences for this new oral thromboprophylaxis agent.

Methods: Face-to-face interviews were conducted with 73 doctors and nurses in 12 German hospitals, 195 current hip and knee replacement patients in six German rehabilitation hospitals, and 202 former thromboprophylaxis patients. Qualitative questions were complemented by a full-profile ranking-based conjoint analysis regarding alternative thromboprophylaxis regimens.

Results: Nearly 100% of the interviewed medical staff viewed the daily subcutaneous LMWH injection as a source of inconvenience for patients. However, both current and former patients perceived their discomfort to be much less intense. In contrast, the conjoint estimates of preferences showed that older and male patients in particular understated their levels of discomfort in a face-to-face interview situation and had a strong preference for oral anticoagulation.

Conclusions: Patients in Germany appear to have a positive preference for oral thromboprophylaxis after major orthopedic surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I
Fig. 2
Table II
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Colwell Jr CW. Thromboprophylaxis in orthopaedic surgery. Am J Orthop 2006; Suppl:1–9: quiz 10–1

  2. Böttner F, Sulco TP, Sharrock NE, et al. Thromboprophylaxis after hip surgeries [in German]. Orthopäde 2001; 30: 890–6

    Article  PubMed  Google Scholar 

  3. Van Aken H, Bode C, Darius H, et al. Anticoagulation: the present and future. Clin Appl Thromb Hemost 2001; 7: 195–204

    Article  PubMed  Google Scholar 

  4. Hawkins D. Pharmacoeconomics of thrombosis management. Pharmacotherapy 2004; 24: 95–9S

    Article  Google Scholar 

  5. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2005; 126(3 Suppl.): 338–400S

    Google Scholar 

  6. AWMF. Inpatient and outpatient thromboprophylaxis in surgical and pre-surgical cases [in German; online]. Available from URL: http://www.uni-duesseldorf.De/awmf/ll/003-001.htm [Accessed 2009 Jan 5]

  7. Lipp H-P, Goldinger A, Haussmann W, et al. Anti-thrombotics for therapy and prophylaxis of venous thromboembolism [in German]. Krankenhauspharmazie 2004; 25: 195–210,303-15

    Google Scholar 

  8. Eriksson BI, Dahl OE, Bueller HR, et al. A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Thromb Haemost 2005; 3: 103–11

    Article  PubMed  CAS  Google Scholar 

  9. Eriksson BI, Dahl OE, Rosencher N, et al. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial [published erratum appears in Lancet 2007; 370: 2004]. Lancet 2007; 370: 949–56

    Article  PubMed  CAS  Google Scholar 

  10. Wilke T, Neumann K, Klapper U, et al. Oral anti-coagulation after hip or knee replacement surgery: a process-driven managerial pharmacoeconomic analysis in German hospitals [in German]. Orthopäde 2008; 37: 448–56

    Article  PubMed  CAS  Google Scholar 

  11. Statistical development of population and households [in German]. Publication VI A 1. Wiesbaden: Statistisches Bundesamt, 2007

  12. Gustafsson A, Herrmann A, Huber F, editors. Conjoint measurement: methods and applications. Berlin: Springer, 2007

    Google Scholar 

  13. Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. Pharmacoeconomics 2008; 26(8): 661–77

    Article  PubMed  Google Scholar 

  14. Hait JF, Black WC, Babin BJ, et al. Multivariate data analysis. 6th edition. Upper Saddle River (NJ): Pearson-Prentice Hall, 2005

    Google Scholar 

  15. Moore WL, Gray-Lee J, Louviere JJ. A cross-validity comparison of conjoint analysis and choice models at different levels of aggregation. Marketing Letters 1998; 9: 195–207

    Article  Google Scholar 

  16. Warkentin TE, Greinacher A, editors. Heparin-induced thrombocytopenia. New York: Marcel Dekker, 2004

    Google Scholar 

  17. Schoeffski O, Schulenburg J-M, Graf VD, editors. Evaluations in health economics [in German]. 3rd ed. Berlin: Springer, 2007

    Google Scholar 

  18. Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med 1992; 34: 507–13

    Article  PubMed  CAS  Google Scholar 

  19. Spahn G. Compliance with self administration of heparin injections in outpatients. Eur J Trauma 2002; 2: 104–9

    Article  Google Scholar 

  20. Tribout B, Colin-Mercier F. New versus established drugs in venous thromboprophylaxis: efficacy and safety considerations related to timing of administration. Am J Cardiovasc Drugs 2007; 7: 1–15

    Article  PubMed  CAS  Google Scholar 

Download references

The survey was financially supported by Boehringer Ingelheim. The author would like to thank an anonymous reviewer as well as Ms Silke Hastedt and Ms Dallas Reese for their very helpful comments. The study design, the collection/analysis/interpretation of the data, and the writing of the report was performed independently of the funder. The author has previously received honoraria from Boehringer Ingelheim.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas Wilke.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilke, T. Patient Preferences for an Oral Anticoagulant after Major Orthopedic Surgery. Patient-Patient-Centered-Outcome-Res 2, 39–49 (2009). https://doi.org/10.2165/01312067-200902010-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/01312067-200902010-00005

Keywords

Navigation